Healthcare provider profile · identity verified

Nebasi Valantine, MD

Family Practice · COON RAPIDS, MN · NPI 1134623721

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	688	179
Amlodipine Besylate	Amlodipine Besylate	406	122
Lisinopril	Lisinopril	358	95
Omeprazole	Omeprazole	303	88
Losartan Potassium	Losartan Potassium	262	77
Hydrochlorothiazide	Hydrochlorothiazide	232	64
Levothyroxine Sodium	Levothyroxine Sodium	217	61
Simvastatin	Simvastatin	212	60
Metformin Hcl	Metformin Hcl	200	53
Tamsulosin Hcl	Tamsulosin Hcl	196	57
Metoprolol Succinate	Metoprolol Succinate	186	49
Potassium Chloride	Potassium Chloride	171	47
Rosuvastatin Calcium	Rosuvastatin Calcium	143	44
Allopurinol	Allopurinol	140	39
Carvedilol	Carvedilol	125	36
Metformin Hcl Er	Metformin Hcl	122	34
Gabapentin	Gabapentin	120	35
Eliquis	Apixaban	110	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	110	27
Fluoxetine Hcl	Fluoxetine Hcl	109	26
Sertraline Hcl	Sertraline Hcl	95	24
Jardiance	Empagliflozin	92	22
Glimepiride	Glimepiride	87	19
Alprazolam	Alprazolam	84	21
Metoprolol Tartrate	Metoprolol Tartrate	81	30
Tramadol Hcl	Tramadol Hcl	77	15
Clopidogrel	Clopidogrel Bisulfate	74	19
Furosemide	Furosemide	73	27
Zolpidem Tartrate	Zolpidem Tartrate	71	25
Spironolactone	Spironolactone	70	23
Warfarin Sodium	Warfarin Sodium	68	16
Pantoprazole Sodium	Pantoprazole Sodium	66	22
Pravastatin Sodium	Pravastatin Sodium	64	17
Ezetimibe	Ezetimibe	61	14
Clonazepam	Clonazepam	60	16
Albuterol Sulfate Hfa	Albuterol Sulfate	56	28
Irbesartan	Irbesartan	55	14
Atenolol	Atenolol	54	15
Meloxicam	Meloxicam	54	16
Famotidine	Famotidine	51	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	48	14
Quetiapine Fumarate	Quetiapine Fumarate	48	suppressed
Finasteride	Finasteride	45	11
Pioglitazone Hcl	Pioglitazone Hcl	44	15
Januvia	Sitagliptin Phosphate	43	suppressed
Diclofenac Sodium	Diclofenac Sodium	42	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	42	12
Benazepril Hcl	Benazepril Hcl	39	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	11
Diazepam	Diazepam	37	suppressed
Glipizide	Glipizide	36	suppressed
Ozempic	Semaglutide	36	suppressed
Lorazepam	Lorazepam	32	suppressed
Chlorthalidone	Chlorthalidone	30	suppressed
Duloxetine Hcl	Duloxetine Hcl	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	29	12
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Glipizide Er	Glipizide	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Valsartan	Valsartan	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Alendronate Sodium	Alendronate Sodium	25	suppressed
Gemfibrozil	Gemfibrozil	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	24	suppressed
Prednisone	Prednisone	24	16
Celecoxib	Celecoxib	23	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Klor-Con M20	Potassium Chloride	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Amoxicillin	Amoxicillin	20	13
Buspirone Hcl	Buspirone Hcl	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Testosterone	Testosterone	20	suppressed
Trazodone Hcl	Trazodone Hcl	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	19	11
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Fosinopril Sodium	Fosinopril Sodium	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Niacin Er	Niacin	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	15
Bupropion Xl	Bupropion Hcl	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Azelastine-Fluticasone	Azelastine/Fluticasone	16	suppressed
Montelukast Sodium	Montelukast Sodium	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Temazepam	Temazepam	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Ramipril	Ramipril	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Cephalexin	Cephalexin	13	12
Enalapril Maleate	Enalapril Maleate	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	12	suppressed
Azithromycin	Azithromycin	12	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Nystatin	Nystatin	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Baclofen	Baclofen	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error